Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-CACI 2024 Congresses
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
El Salvador 2024 Sessions
Arequipa 2024 Sessions
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/IASC Clinical Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Related Organizations
Institutional News
Contact
Search
Search
Search
SOLACI Congress
SOLACI-CACI 2024
SOLACI-CACI 2024 Certificates
Selected Presentations Day 1
Selected Presentations Day 2
Selected Presentations Day 3
Coverage and News
Facebook
Instagram
Linkedin
Twitter
Youtube
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-CACI 2024 Congresses
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
El Salvador 2024 Sessions
Arequipa 2024 Sessions
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/IASC Clinical Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Related Organizations
Institutional News
Contact
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-CACI 2024 Congresses
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
El Salvador 2024 Sessions
Arequipa 2024 Sessions
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/IASC Clinical Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Related Organizations
Institutional News
Contact
Home
Structural heart disease
Valvular Aortic Valve
Valvular Aortic Valve
Valvular Aortic Valve
Valvular Aortic valve
Other
Hypertrophic Cardiomyopathy
Left Atrial Apendix Closure
Arterial Accesses
Valvular Aortic Valve
View Category
Structural heart disease
High Gradients After Valve-in-Valve
One of the limitations of aortic bioprostheses is their durability. When these devices fail, percutaneous valve implantation...
solaci
-
18 June, 2024
Learn More
Structural heart disease
Low-Flow Aortic Stenosis: What is the Value of Valve Calcification in its Interpretation?
Delays in the treatment of symptomatic aortic stenosis (AS) reduce prognosis, especially in elderly patients. Accurate assessment...
solaci
-
7 June, 2024
Learn More
Structural heart disease
TAVR vs SAVR in Los Risk Patients: 10-Year Outcomes of the NOTION Trial
Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of patients with severe aortic stenosis (AS). Randomized...
solaci
-
28 May, 2024
Learn More
Structural heart disease
Third Generation Balloon-Expandable and Self-Expanding Valves: TAVR Meta- Analysis
TAVR’s significant advance has driven the development of valve technology, which is currently in its third generation. Even...
solaci
-
24 May, 2024
Learn More
Structural Heart Disease
EuroPCR 2024 | Self-Expanding Valves (ACURATE Neo2) vs. Balloon-Expandable Valves (Sapien 3 Ultra): 1-Year Follow-up Results
Comparing different transcatheter heart valves (THVs) is necessary to obtain relevant information that facilitates the selection of...
solaci
-
22 May, 2024
Learn More
Structural Heart Disease
EuroPCR 2024 | NOTION-2: TAVI vs SAVR, Randomized Study on Low-Risk Young Patients with Severe Tricuspid Disease or Bicuspid Stenosis
Many of the studies comparing TAVR against SAVR in low risk patients included patients between 70-75 years,...
solaci
-
17 May, 2024
Learn More
Structural Heart Disease
EuroPCR 2024 | OBSERVANT II: TAVR in the “Real World”
This study analyzed 2,493 “real world” patients, 1,352 receiving the Evolut R/Pro, 675 the SAPIEN, 3,270 the...
solaci
-
15 May, 2024
Learn More
Structural Heart Disease
EuroPCR 2024 | SOLVE-TAVI: Self Expanding or Balloon Expandable Valves?
This was a randomized study with 447 patients carried out to compare the 5-year evolution of TAVR...
solaci
-
15 May, 2024
Learn More